RankAlpha logo
Back to Rankings

NVS

NovartisB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Execution beats on core portfolio and successful launches/approvals push revenue and margin upside; cost discipline and share buybacks support multiple expansion toward the analyst high (~$175) as investors re-rate growth optionality.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Accelerated biosimilar/generic erosion in key markets
Momentum
80
Value
62
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $144.40 · Bull $175.00 · Bear $109.51Analysis 2026-02-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-04 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $151.96
Why
Momentum80 · Δ7d +22.9
Value62 · Δ7d +0.0
Sentiment51 · Δ7d +0.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta +0.0.

Contradictions & invalidation

  • • Accelerated biosimilar/generic erosion in key markets
  • • Adverse currency moves affecting reported results
  • • Pricing pressure, unexpected generic/biosimilar competition, or guidance shortfall could drive downside toward analyst lows (~$109.51); FX or one-off charges could exacerbate volatility and investor flight from the name.

Catalyst clock

2026-02-04

FY2025 Earnings Release

Lead driver: Value · See fundamentals
Momentum
80
8% active weight
Current posture
7d trendImproving
Δ7d
+22.9
Δ21d
+54.3
Value
62
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.9
Sentiment
51
45% active weight
Current posture
7d trendSoftening
Δ7d
+0.7
Δ21d
-16.9
Why this grade

Composite grade B. Momentum 79.8 / Value 62.4 / Sentiment 51.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-04. Scenario method

B+
Bull case
25%
Probability
Target price
$175.00
Analysis reference price unavailable
Analysis 2026-02-04 · RankAlpha Sentiment AI
Most likely
B
Base case
55%
Probability
Target price
$144.40
Analysis reference price unavailable
Analysis 2026-02-04 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$109.51
Analysis reference price unavailable
Analysis 2026-02-04 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$276.59B
Beta
0.78
Shares Out
1.83B
P/E (TTM)
18.7
P/S (TTM)
5.16
P/FCF (TTM)
31.31
Rev YoY
+1.0%
EPS YoY
-18.7%
Gross Margin
+74.1%
Op Margin
+29.6%
Net Debt
$23.79B
Current Ratio
0.86
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data